1. 邵肖梅,叶鸿瑁,丘小汕.实用儿新生儿学.第4版.北京:人民卫生出版社,2011.
2. 中华医学会儿科学分会新生儿学组.新生儿黄疸诊疗原则的专家共识.中华儿科杂志,2010,48(9):685-696.
3. 沈刚.新编实用儿科药物手册.第2版.北京:人民军医出版社,2009.
4. Perlman JM.Intervention strategies for neonatal hypoxic-ischemic cerebral injury.Clin Ther,2006,28:1353-1365.
5. Konduri GG,Kim UO.Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn.Pediatr Clin North Am,2009,56:579-600.
6. Gras L,Wallon M,Pollak A,et al.Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy:A cohort study in European centres.Acta Paediatr,2005,94:1721-1731.
7. Kattwinkel J,Bloom BT,Delmore P,et al.High-versus low-threshold surfactant retreatment for neonatal respiratory distress syndrome.Pediatrics,2000,106:282-288.
8. Alfaleh K,Smyth JA,Roberts Rs,et al.Prevention and 18-month outcome of serious pulmonary hemorrhage in extremely low birth weight infants:results from the trials of indomethacin in prophylaxis in preterms.Pediatrics,2008,121:233-238.
9. Ostrea EM,Villanueva-Uy ET,Natarajan G,et al.Persistent pulmonary hypertension of the newborn with transposition of the treat arteries:successful treatment with bosentan.Eur J Pediatr,2008,167:437-440.